None listed
Conditions
Interventions
Dietary Supplement : This study aims to compare and evaluate the bioavailability and safety of Liposomal ABmax Multivitamin (T, L, S, M) with conventional control supplements. The study follows a rand
Sponsors
Silla University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Participants who voluntarily provide written informed consent after receiving a full explanation of the study Body Mass Index (BMI) between 18.5 and 29.9 kg/m² No history of serious illness within 3 months prior to participation Individuals who can fully comply with the study schedule, including supplementation and blood sampling procedures Non-pregnant and non-lactating women who agree to use an appropriate method of contraception during the study
Exclusion criteria
Exclusion criteria: Individuals with a known allergy or hypersensitivity to any component of the test or control supplements Those who have taken vitamin or mineral supplements within 3 days prior to the study Individuals diagnosed with chronic diseases (e.g., diabetes, hypertension, liver disease, kidney disease, cardiovascular diseases, immune disorders) Participants with a history of psychiatric disorders (e.g., depression, anxiety disorders) or currently undergoing treatment Those who have participated in another clinical or human trial within the last 3 months Smokers (=10 cigarettes per day) or individuals with excessive alcohol consumption (=14 drinks per week) Pregnant or lactating women Individuals deemed unsuitable for participation by the investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparison of blood concentrations and pharmacokinetic parameters (Cmax, Tmax, iAUC, t1/2) of vitamins and minerals (Vitamin B3, Vitamin C, Iron, Zinc) | — |
Secondary
| Measure | Time frame |
|---|---|
| Comparison of frequency and severity of adverse events (AEs) between test and control products | — |
Countries
Korea, Republic of
Contacts
Public ContactANDRE KIM
Silla University
Outcome results
None listed